Christian S Hinrichs

11PUBLICATIONS
64CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Separation technologiesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 15, 2025
Respiration defects limit serine synthesis required for lung cancer growth and survival.

Eduardo Cararo Lopes, Fuqian Shi, Akshada Sawant

|Jun 26, 2025
GPC2-Targeted CAR T Cells Engineered with NFAT-Inducible Membrane-Tethered IL15/IL21 Exhibit Enhanced Activity against Neuroblastoma.

Reona Okada, Jeyshka M Reyes-González, Constanza Rodriguez

|Apr 09, 2025
CD22 TCR-engineered T cells exert antileukemia cytotoxicity without causing inflammatory responses.

Kilyna A Nguyen, Zhihui Liu, John S Davies

|Jan 09, 2025
Immune Checkpoint Blockade Delays Cancer Development and Extends Survival in DNA Polymerase Mutator Syndromes.

Akshada Sawant, Fuqian Shi, Eduardo Cararo Lopes

|Dec 06, 2023
Publisher Correction: CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides.

Guillaume Gaud, Sooraj Achar, François X P Bourassa

|Nov 09, 2023
CD3ζ ITAMs enable ligand discrimination and antagonism by inhibiting TCR signaling in response to low-affinity peptides.

Guillaume Gaud, Sooraj Achar, François X P Bourassa

Pageof 2

Frequent Collaborators

4 joint publications

Naomi Taylor

4 joint publications

John S Davies

3 joint publications

Sooraj R Achar

3 joint publications

Michael C Kelly